Skip to main content

Advertisement

Log in

Indicative findings of pancreatic cancer in prediagnostic CT

  • Hepatobiliary-Pancreas
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

We examined 20 prediagnostic CTs from 16 patients for whom the diagnosis of pancreatic cancer was delayed until full diagnostic CT was performed. Three radiologists independently reviewed the prediagnostic CTs along with 50 CTs of control subjects, including patients without pancreatic disease (n = 38) or with chronic pancreatitis without calcification visible on CT (n = 12). The reviewers recorded the presence of biliary or pancreatic ductal dilation, interruption of the pancreatic duct, distal parenchymal atrophy, contour abnormality and focal hypoattenuation. Frequency, sensitivity and specificity of the significant findings were calculated. Logistic regression analysis was performed. Findings indicative of pancreatic cancer were seen on 85% (17/20) of the prediagnostic CTs. Patients with pancreatic cancer were significantly (p < 0.05) more likely to show focal hypoattenuation, pancreatic duct dilation, interruption of the pancreatic duct, and distal parenchymal atrophy, with sensitivities and specificities of 75%/84%, 50%/78%, 45%/82% and 45%/96%, respectively. Focal hypoattenuation and distal parenchymal atrophy were the independent predictors of pancreatic cancer with odds ratios of 20.92 and 11.22, respectively. In conclusion, focal hypoattenuation and pancreatic duct dilation with or without interruption, especially when accompanied by distal parenchymal atrophy, were the most useful findings for avoiding delayed diagnosis of pancreatic cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Schima W, Ba-Ssalamah A, Kolblinger C, Kulinna-Cosentini C, Puespoek A, Gotzinger P (2007) Pancreatic adenocarcinoma. Eur Radiol 17:638–649

    Article  PubMed  Google Scholar 

  2. Eskelinen MJ, Haglund UH (1999) Prognosis of human pancreatic adenocarcinoma: review of clinical and histopathological variables and possible uses of new molecular methods. Eur J Surg 165:292–306

    Article  PubMed  CAS  Google Scholar 

  3. Smith SL, Rajan PS (2004) Imaging of pancreatic adenocarcinoma with emphasis on multidetector CT. Clin Radiol 59:26–38

    Article  PubMed  CAS  Google Scholar 

  4. Warshaw AL, Fernandez-del Castillo C (1992) Pancreatic carcinoma. N Engl J Med 326:455–465

    PubMed  CAS  Google Scholar 

  5. Li D, Xie K, Wolff R, Abbruzzese JL (2004) Pancreatic cancer. Lancet 363:1049–1057

    Article  PubMed  CAS  Google Scholar 

  6. Tamm EP, Silverman PM, Charnsangavej C, Evans DB (2003) Diagnosis, staging, and surveillance of pancreatic cancer. AJR Am J Roentgenol 180:1311–1323

    PubMed  Google Scholar 

  7. Prokesch RW, Chow LC, Beaulieu CF, Bammer R, Jeffrey RB Jr (2002) Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology 224:764–768

    Article  PubMed  Google Scholar 

  8. Gangi S, Fletcher JG, Nathan MA et al (2004) Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis. AJR Am J Roentgenol 182:897–903

    PubMed  Google Scholar 

  9. Bronstein YL, Loyer EM, Kaur H et al (2004) Detection of small pancreatic tumors with multiphasic helical CT. AJR Am J Roentgenol 182:619–623

    PubMed  Google Scholar 

  10. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174

    Article  PubMed  CAS  Google Scholar 

  11. Demachi H, Matsui O, Kobayashi S et al (1997) Histological influence on contrast-enhanced CT of pancreatic ductal adenocarcinoma. J Comput Assist Tomogr 21:980–985

    Article  PubMed  CAS  Google Scholar 

  12. Kim T, Murakami T, Takamura M et al (2001) Pancreatic mass due to chronic pancreatitis: correlation of CT and MR imaging features with pathologic findings. AJR Am J Roentgenol 177:367–371

    PubMed  CAS  Google Scholar 

  13. Ichikawa T, Sou H, Araki T et al (2001) Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology 221:107–116

    Article  PubMed  CAS  Google Scholar 

  14. Lee H, Lee JK, Kang SS et al (2007) Is there any clinical or radiologic feature as a preoperative marker for differentiating mass-forming pancreatitis from early-stage pancreatic adenocarcinoma? Hepatogastroenterology 54:2134–2140

    PubMed  Google Scholar 

  15. Tanaka S, Nakaizumi A, Ioka T et al (2002) Main pancreatic duct dilatation: a sign of high risk for pancreatic cancer. Jpn J Clin Oncol 32:407–411

    Article  PubMed  Google Scholar 

  16. Ishikawa O, Ohigashi H, Imaoka S et al (1999) Minute carcinoma of the pancreas measuring 1 cm or less in diameter—collective review of Japanese case reports. Hepatogastroenterology 46:8–15

    PubMed  CAS  Google Scholar 

  17. Hruban RH, Adsay NV, Albores-Saavedra J et al (2001) Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 25:579–586

    Article  PubMed  CAS  Google Scholar 

  18. Karasawa E, Goldberg HI, Moss AA, Federle MP, London SS (1983) CT pancreatogram in carcinoma of the pancreas and chronic pancreatitis. Radiology 148:489–493

    PubMed  CAS  Google Scholar 

  19. Brune K, Abe T, Canto M et al (2006) Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Pathol 30:1067–1076

    PubMed  Google Scholar 

  20. Patlas M, Deitel W, Taylor B, Gallinger S, Wilson SR (2007) Focal chronic pancreatitis mimicking pancreatic head carcinoma: are there suggestive features on ultrasound? Can Assoc Radiol J 58:15–21

    PubMed  Google Scholar 

  21. Freeny PC, Bilbao MK, Katon RM (1976) “Blind” evaluation of endoscopic retrograde cholangiopancreatography (ERCP) in the diagnosis of pancreatic carcinoma: the “double duct” and other signs. Radiology 119:271–274

    PubMed  CAS  Google Scholar 

  22. Plumley TF, Rohrmann CA, Freeny PC, Silverstein FE, Ball TJ (1982) Double duct sign: reassessed significance in ERCP. AJR Am J Roentgenol 138:31–35

    PubMed  CAS  Google Scholar 

  23. Menges M, Lerch MM, Zeitz M (2000) The double duct sign in patients with malignant and benign pancreatic lesions. Gastrointest Endosc 52:74–77

    Article  PubMed  CAS  Google Scholar 

  24. Ahualli J (2007) The double duct sign. Radiology 244:314–315

    Article  PubMed  Google Scholar 

  25. Irie H, Honda H, Kaneko K, Kuroiwa T, Yoshimitsu K, Masuda K (1997) Comparison of helical CT and MR imaging in detecting and staging small pancreatic adenocarcinoma. Abdominal imaging 22:429–433

    Article  PubMed  CAS  Google Scholar 

  26. Gore RM, Levine MS (2008) Textbook of gastrointestinal radiology, 3rd edn. Saunders, Philadelphia, PA

    Google Scholar 

  27. Glaser J, Stienecker K (2000) Pancreas and aging: a study using ultrasonography. Gerontology 46:93–96

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank Eun Hee Choi, Department of Biostatistics, Severance Hospital, for the statistical consultation and analysis of data.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Myeong-Jin Kim.

Additional information

This paper was presented at the 2008 RSNA Annual Meeting.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ahn, S.S., Kim, MJ., Choi, JY. et al. Indicative findings of pancreatic cancer in prediagnostic CT. Eur Radiol 19, 2448–2455 (2009). https://doi.org/10.1007/s00330-009-1422-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-009-1422-6

Keywords

Navigation